Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker PMCB
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 13, 2026 | PMCB PharmaCyte Biotech, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 13, 2026 | PMCB PharmaCyte Biotech, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 13, 2026 | PMCB PharmaCyte Biotech, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Oct 16, 2026 | PMCB PharmaCyte Biotech, Inc. | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
| Apr 2, 2026 | PMCB PharmaCyte Biotech, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Apr 2, 2026 | PMCB PharmaCyte Biotech, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 5, 2025 | PMCB PharmaCyte Biotech, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Oct 31, 2025 | PMCB PharmaCyte Biotech, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Oct 31, 2025 | PMCB PharmaCyte Biotech, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 5, 2025 | PMCB PharmaCyte Biotech, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 5, 2025 | PMCB PharmaCyte Biotech, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Sep 5, 2025 | PMCB PharmaCyte Biotech, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 18, 2025 | PMCB PharmaCyte Biotech, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 18, 2025 | PMCB PharmaCyte Biotech, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Aug 18, 2025 | PMCB PharmaCyte Biotech, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 24, 2025 | PMCB PharmaCyte Biotech, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Feb 26, 2025 | PMCB PharmaCyte Biotech, Inc. | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
17 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:35 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances